<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-24T17:46:04Z</responseDate><request verb="GetRecord" identifier="oai:dspace.unza.zm:123456789/573" metadataPrefix="dim">https://dspace.unza.zm/server/oai/request</request><GetRecord><record><header><identifier>oai:dspace.unza.zm:123456789/573</identifier><datestamp>2019-08-19T14:27:37Z</datestamp><setSpec>com_123456789_5087</setSpec><setSpec>com_123456789_18</setSpec><setSpec>col_123456789_6021</setSpec><setSpec>col_123456789_83</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Masebe, Mukokomena Esther</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2011-07-13T12:01:37Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2011-07-13T12:01:37Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2011-07-13</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis.  &#xd;
There were 14.4 million individuals worldwide living with TB including half a million cases of Multidrug-resistant (MDR) TB in 2006. A most serious aspect of the problem has been the emergence of MDR-TB and extensively drug-resistant (XDR) TB.  &#xd;
MDR-TB is defined as a strain of Mycobacterium tuberculosis that is resistant to at least Isoniazid and Rifampicin whether there is resistance to other drugs or not. XDR-TB is defined as resistance to at least rifampicin, isoniazid, a second line injectable drug (capreomycin, kanamycin or amikacin) and a fluoroquinolone.China, India and the Russian Federation are thought to carry the largest MDR-TB global caseload. World Health Organization (WHO) estimates that there were 66,700 MDR-TB cases in Africa in 2006. In 2005 approximately 50 cases were reported as having MDR-TB in Zambia.  Treatment of MDR-TB requires prolonged and expensive chemotherapy. The main objective of this study was to determine the prevalence of and factors associated with MDR-TB among adults with TB at University Teaching Hospital (UTH) in Lusaka, Zambia. Specific objectives were to describe the demographic characteristic of patients presenting with MDR-TB, determine the proportion of MDR-TB cases among TB culture-positive patients, and to determine the association between HIV/AIDS, previous TB treatment and compliance on one hand and MDR-TB on the other.A cross-sectional study was conducted in UTH TB Laboratory in Lusaka among culture-positive TB patients. Facility TB records and databases for M tuberculosis isolates which were cultured and had drug-sensitivity testing performed against four first-line anti-TB drugs were studied retrospectively. All the records and databases available between 2003 and 2008 were reviewed.  The results have been presented in graphical and tabular form. The proportion of MDR-TB among the TB culture-positive patients was 10.9%. The association between age and MDR-TB was not statistically significant. The observed proportions of females between positive and negative were statistically different. There was no significant association between employment status and MDR-TB. There was an association between HIV/AIDS and MDR-TB. There was an association between compliance and MDR-TB.We conclude that there is need for continuous monitoring of MDR-TB and XDR-TB.</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://dspace.unza.zm/handle/123456789/573</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Cholera</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Immunization</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Typhod Fever</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">Acceptability of Oral Immunization Against Cholera and Typhod Fever among School Children in Lusaka</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>